Publication | Closed Access
Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
201
Citations
17
References
2019
Year
177Lu-dotatate PrrtFirst Clinical ExperienceMedicinePharmacologyNeuroendocrine DisorderPharmacotherapyCancer TreatmentOncologyRadiation OncologyNuclear MedicineCancer ResearchEndocrine-related Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1